NCT04929223 2026-03-03A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)Hoffmann-La RochePhase 1 Recruiting542 enrolled
NCT05681039 2026-03-02Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).M.D. Anderson Cancer CenterPhase 2 Recruiting29 enrolled